Bristol-Myers Squibb to Take Part at the Wolfe Research Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Bristol-Myers Squibb (BMY) Tops Q3 EPS by 10c, Updattes FY Guidance
October 31, 2019 7:02 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $1.17, $0.10 better than the analyst estimate of $1.07. Revenue for the quarter came in at $6.01 billion versus the consensus estimate of $5.89 billion.
GUIDANCE:
Bristol-Myers Squibb sees Q4 2019 EPS of $4.25-$4.35, versus the consensus of... More
